Business · 04/08/1994Updated: 10/16/2026 · 1 min read
Glaxo, Inc., et al.; Withdrawal of Approval of 13 Abbreviated Antibiotic Applications and 2 Abbreviated New Drug Applications
Summary
The Food and Drug Administration (FDA) is withdrawing approval of 15 applications for antibiotic and new drug products, as the holders have notified the agency that the products are no longer being marketed.
Original source language: Federal Register — Health and Human ServicesOpen original release →